---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-034510"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2023-10-17T23:59:59+00:00"
generated_at: "2026-06-09T22:36:37.608345+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Avalo Therapeutics lowers stockholder meeting quorum from majority to one-third

## Summary
- Board approved Fourth Amended and Restated Bylaws on October 16, 2023, effective immediately.
- Quorum reduced to one-third of shares entitled to vote, present in person or by proxy.
- Previous requirement was a majority of shares present in person or by proxy.

## SEC filing metadata
- accession: 0001628280-23-034510
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2023-10-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828023034510/0001628280-23-034510-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828023034510/avtx-20231016.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-034510
- JSON: https://secwatch.observer/filing/0001628280-23-034510.json
- Plain text: https://secwatch.observer/filing/0001628280-23-034510.txt

## Key facts
- Governance Changes
  Avalo Therapeutics, Inc.: Amended quorum requirement for stockholder meetings from majority of shares present to one-third of shares entitled to vote (effective 2023-10-16).
  - Change: bylaw amendment
  - Effective: 2023-10-16
  source text: On October 16, 2023, the Board of Directors of Avalo Therapeutics, Inc. (the “Company”) approved the Company’s Fourth Amended and Restated Bylaws, effective immediately upon approval by the Board (the “Amended and Restated Bylaws”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534120/000162828023034510/0001628280-23-034510-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.